NOVAREX Co.,Ltd. (KOSDAQ: 194700)

Market Cap	172.24B
Revenue (ttm)	295.18B
Net Income (ttm)	22.19B
Shares Out	17.70M
EPS (ttm)	1,253.83
PE Ratio	7.76
Forward PE	8.63
Dividend	200.00 (2.06%)
Ex-Dividend Date	n/a

Volume	24,501
Open	9,800
Previous Close	9,730
Day's Range	9,800 - 10,060
52-Week Range	8,840 - 13,880
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2024

About NOVAREX Co.,Ltd.

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 414
• Stock Exchange: KOSDAQ
• Ticker Symbol: 194700

Financial Performance

In 2023, NOVAREX Co.,Ltd.'s revenue was 302.17 billion, an increase of 7.28% compared to the previous year's 281.68 billion. Earnings were 22.04 billion, an increase of 10.26%.